Evidence map›Paper›PMID 26974342›Full record

ArticleeLife2016

GSK3β regulates AKT-induced central nervous system axon regeneration via an eIF2Bε-dependent, mTORC1-independent pathway.

Xinzheng Guo, William D Snider, Bo Chen

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Genes in Axonal Regeneration.Molecular neurobiology · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Posttranslational modifications of proteins in diseased retina.Frontiers in cellular neuroscience · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Xinzheng GuoDepartment of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, United States.
William D SniderUNC Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, United States.
Bo ChenDepartment of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, United States.ORCID http://orcid.org/0000-0003-2768-9007
Yale University · USUniversity of North Carolina at Chapel Hill · US

Funding

HDAC4-mediated Photoreceptor Protection in Retinal DegenerationR01EY021502 · NEI · YALE UNIVERSITY · PI CHEN, BO · 2012 to 2016
$2.0M
Regeneration of rod photoreceptors from Muller glial cells in adult mouse retinaR01EY024986 · NEI · YALE UNIVERSITY · PI CHEN, BO · 2016 to 2019
$1.6M
NEI NIH HHS R01 EY021502NEI NIH HHS R01 EY024986
6 · The paper itself

Abstract

Axons fail to regenerate after central nervous system (CNS) injury. Modulation of the PTEN/mTORC1 pathway in retinal ganglion cells (RGCs) promotes axon regeneration after optic nerve injury. Here, we report that AKT activation, downstream of Pten deletion, promotes axon regeneration and RGC survival. We further demonstrate that GSK3β plays an indispensable role in mediating AKT-induced axon regeneration. Deletion or inactivation of GSK3β promotes axon regeneration independently of the mTORC1 pathway, whereas constitutive activation of GSK3β reduces AKT-induced axon regeneration. Importantly, we have identified eIF2Bε as a novel downstream effector of GSK3β in regulating axon regeneration. Inactivation of eIF2Bε reduces both GSK3β and AKT-mediated effects on axon regeneration. Constitutive activation of eIF2Bε is sufficient to promote axon regeneration. Our results reveal a key role of the AKT-GSK3β-eIF2Bε signaling module in regulating axon regeneration in the adult mammalian CNS.

Indexed as

RegenerationAnimalsAxonsEukaryotic Initiation Factor-2Glycogen Synthase Kinase 3 betaMechanistic Target of Rapamycin Complex 1Mice, Inbred C57BLMultiprotein ComplexesOncogene Protein v-aktOptic Nerve InjuriesRetinal Ganglion CellsTOR Serine-Threonine KinasesEukaryotic Initiation Factor-2Glycogen Synthase Kinase 3 betaMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesOncogene Protein v-aktTOR Serine-Threonine Kinasesaxon injuryCNS axon regenerationmouseneurosciencesignal transduction

Identifiers

PMID26974342
PMCPMC4805534
OpenAlexW2299964852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.